Cargando…
Hyperoside, a Flavonoid Compound, Inhibits Proliferation and Stimulates Osteogenic Differentiation of Human Osteosarcoma Cells
Osteosarcoma, one of the most common malignant bone tumours, is generally considered a differentiation disease caused by genetic and epigenetic disruptions in the terminal differentiation of osteoblasts. Novel therapies based on the non-cytotoxic induction of cell differentiation-responsive pathways...
Autores principales: | Zhang, Ning, Ying, Mei-Dan, Wu, Yong-Ping, Zhou, Zhi-Hong, Ye, Zhao-Ming, Li, Hang, Lin, Ding-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077650/ https://www.ncbi.nlm.nih.gov/pubmed/24983940 http://dx.doi.org/10.1371/journal.pone.0098973 |
Ejemplares similares
-
Hyperoside ameliorates periodontitis in rats by promoting osteogenic differentiation of BMSCs via activation of the NF‐κB pathway
por: Xu, Tao, et al.
Publicado: (2020) -
Antioxidant Activity Evaluation of Dietary Flavonoid Hyperoside Using Saccharomyces Cerevisiae as a Model
por: Gao, Yuting, et al.
Publicado: (2019) -
Defective Osteogenic Differentiation in the Development of Osteosarcoma
por: Wagner, Eric R., et al.
Publicado: (2011) -
The Role of Flavonoids in the Osteogenic Differentiation of Mesenchymal Stem Cells
por: Zhang, Jinli, et al.
Publicado: (2022) -
Osteosarcoma (Osteogenic sarcoma)
por: Picci, Piero
Publicado: (2007)